Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alexanian

Showing results (51-60 of 196) with videos related to

Pageof 20
Sort By:
Blood|September 1, 1972
Oxymetholone treatment for the anemia of bone marrow failureR Alexanian, J Nadell, C Alfrey
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 19, 2015
Specific combinations of the chromatin-modifying enzyme modulators significantly attenuate glioblastoma cell proliferation and viability while exerting minimal effect on normal adult stem cells growthArshak R Alexanian, Yi-Wen Huang
Assay and Drug Development Technologies|February 23, 2022
Modifications to the Transwell Migration/Invasion Assay Method That Eases Assay Performance and Improves the AccuracyHeidi Marie Stoellinger, Arshak R Alexanian
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 1999
Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaBA R Alexanian, J R Bamburg
Archives of Internal Medicine|August 1, 1990
Renal failure in multiple myeloma. Pathogenesis and prognostic implicationsR Alexanian, B Barlogie, D Dixon
Archives of Internal Medicine|September 1, 1988
Prognosis of asymptomatic multiple myelomaR Alexanian, B Barlogie, D Dixon
American Journal of Hematology|February 1, 1990
VAD-based regimens as primary treatment for multiple myelomaR Alexanian, B Barlogie, S Tucker
Experimental Neurology|July 31, 2001
Proliferation and regeneration of retrogradely labeled adult rat corticospinal neurons in cultureA R Alexanian, H O Nornes
Neuroscience|April 5, 2003
Differentiating adult hippocampal stem cells into neural crest derivativesA R Alexanian, M Sieber-Blum
JAMA|November 25, 1992
Plasma cell dyscrasiasB Barlogie, R Alexanian, S Jagannath
Pageof 20

Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Blood|September 1, 1972
Oxymetholone treatment for the anemia of bone marrow failureR Alexanian, J Nadell, C Alfrey
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 19, 2015
Specific combinations of the chromatin-modifying enzyme modulators significantly attenuate glioblastoma cell proliferation and viability while exerting minimal effect on normal adult stem cells growthArshak R Alexanian, Yi-Wen Huang
Assay and Drug Development Technologies|February 23, 2022
Modifications to the Transwell Migration/Invasion Assay Method That Eases Assay Performance and Improves the AccuracyHeidi Marie Stoellinger, Arshak R Alexanian
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 1999
Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaBA R Alexanian, J R Bamburg
Archives of Internal Medicine|August 1, 1990
Renal failure in multiple myeloma. Pathogenesis and prognostic implicationsR Alexanian, B Barlogie, D Dixon
Archives of Internal Medicine|September 1, 1988
Prognosis of asymptomatic multiple myelomaR Alexanian, B Barlogie, D Dixon
American Journal of Hematology|February 1, 1990
VAD-based regimens as primary treatment for multiple myelomaR Alexanian, B Barlogie, S Tucker
Experimental Neurology|July 31, 2001
Proliferation and regeneration of retrogradely labeled adult rat corticospinal neurons in cultureA R Alexanian, H O Nornes
Neuroscience|April 5, 2003
Differentiating adult hippocampal stem cells into neural crest derivativesA R Alexanian, M Sieber-Blum
JAMA|November 25, 1992
Plasma cell dyscrasiasB Barlogie, R Alexanian, S Jagannath
Pageof 20